MDCO LTD

Financial Health Score: B-

Explanation: MDCO Ltd possesses the financial constitution of a patient with an excellent immune system but a chronic, underlying illness. The company’s "immunity" is its exceptional liquidity and zero long-term debt, meaning it is in no immediate danger of financial cardiac arrest. However, the "chronic illness" is a persistent decline in overall financial health, with retained earnings and net assets shrinking year after year. The patient is living off past financial reserves rather than generating new, healthy growth.

Key Vital Signs

1. Blood Pressure & Circulation (Liquidity & Cash Flow) * Current Ratio: 4.83:1 (Current Assets £230,975 / Current Liabilities £47,752) * Cash Reserves: £225,422 * Interpretation: The patient’s blood pressure is exceptionally strong. With nearly £5 in current assets for every £1 of short-term debt, the business has more than enough working capital to meet its immediate obligations. The cash reserves act as a robust financial heart, keeping the business well-oxygenated without relying on external blood transfusions (debt).

2. Muscle Mass & Body Weight (Net Assets & Retained Earnings) * Net Assets: £199,886 (Down from £483,861 in 2021) * Retained Earnings: £199,786 (Down from £239,794 in 2025, representing a £40,008 loss in the latest year) * Interpretation: The business is experiencing significant atrophy. Over the last five years, the company's net assets have more than halved. The drop in retained earnings confirms that the business suffered a substantial loss in the latest financial year. The patient is losing weight, and not in a healthy way—this is muscle wastage, not fat loss.

3. Cholesterol Levels (Debt & Liabilities) * Long-term Debt: £0 * Total Liabilities: £47,752 (Mostly trade creditors and tax) * Interpretation: The company's cholesterol levels are perfect. There is no long-term debt clogging the arteries, and the existing liabilities are manageable, routine trade debts and tax obligations. There is no risk of a debt-induced stroke here.

4. Metabolism (Operational Efficiency) * Trade Debtors: £1,353 (Down from £20,213 in 2025) * Trade Creditors: £20,604 (Stable from £20,272 in 2025) * Interpretation: The dramatic drop in trade debtors suggests the business has either collected all outstanding invoices (a positive) or, more concerningly, that sales volume has slowed down significantly, meaning fewer invoices are being generated. With a stable level of trade creditors, the business is still purchasing goods, but the drastic drop in debtors is a symptom of a slowing metabolism.

Diagnosis

Chronic Financial Atrophy with Strong Immune Reserves

MDCO Ltd is currently suffering from a sustained period of trading malaise. While the balance sheet looks superficially healthy due to a massive cash fortress, the underlying vital signs tell a story of a business that is slowly bleeding out its historical reserves.

The transition from £598k in cash (2021) to £225k (2026), and net assets dropping from £483k to £199k over the same period, indicates that the business is consuming its own financial marrow to survive. The latest accounts confirm a £40,008 loss, continuing a multi-year trend of declining equity. The near-total disappearance of trade debtors, combined with only £4,200 in stock, suggests the company's operational engine is running at a very low idle. The patient is not in the emergency room, but they are definitely bedridden and losing strength year over year.

Recommendations

To restore the patient to full health and reverse the atrophy, the following prescriptions are recommended:

1. Stop the Bleeding (Cost Control & Margin Analysis) Before the patient can run, the bleeding must be stopped. Conduct a rigorous review of overheads and cost of goods sold. With only 3 employees and minimal stock, the fixed costs must be evaluated to ensure the business isn't spending money on overheads that do not directly generate revenue.

2. Stimulate the Appetite (Revenue Generation) The drop in debtors to a mere £1,353 is a red flag for a trading business. The company needs a strong dose of sales and marketing medicine to boost top-line revenue. As a specialist chemical supplier, MDCO should explore whether its current product lines still meet market demand or if the industry has moved on to new solutions.

3. Preventative Care (Cash Runway Forecasting) While the cash reserves are currently robust, at the current rate of cash burn (approx. £10k-£15k reduction in cash per year recently, though much higher in earlier years), the company has a long runway. However, cash should be treated as a finite resource. Management must model exactly how long the current cash reserves will last if the business continues to trade at a loss, establishing a "code blue" threshold that triggers drastic action if cash drops below a safe minimum.

4. Review the Asset Base (Motor Vehicles) The company holds £21,045 in motor vehicles (net book value). Given the small size of the operation and the current lack of trading activity, management should evaluate whether these assets are fully utilized or if selling them could provide an additional cash injection and reduce depreciation costs.